The adult antiretroviral treatment and resistance study (Tshepo)
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Didanosine; Efavirenz; Lamivudine; Lamivudine/stavudine; Lamivudine/zidovudine; Nevirapine; Stavudine; Zidovudine
- Indications HIV-1 infections
- Focus Therapeutic Use
- Acronyms Tshepo
- 17 Sep 2012 Biomarkers information updated
- 02 Mar 2011 Results for zidovudine + lamivudine vs stavudine + lamivudine presented at the 18th Conference on Retroviruses and Opportunistic Infections.
- 20 Jul 2010 Results of effects on CD4+ cell counts presented at the 18th International AIDS Conference.